Characteristic N = 484 Death (N = 21) | Cumulative Proportion (%) of deaths (95% CI) | p-value |
---|---|---|
Overall | 4.8 (2.6–7.0) |  |
Sex | Â | 0.018 |
female (n = 209) | 7.8 (3.7–12.0) |  |
male (n = 274) | 2.6 (0.4–4.8) |  |
Age, yrs |  | < 0.001 |
 < 64 (n = 148) | 2,8 (0–5,9) |  |
 65–74 (n = 154) | 1.6 (0–3.8) |  |
 75–84 (n = 137) | 6.8 (2.3–11.3) |  |
 85+ (n = 45) | 17.7 (5.7–29.6) |  |
NIHSS |  | < 0.001 |
 0–4 (n = 265) | 2.3 (0.3–4.3) |  |
 5–15 (n = 178) | 7.2 (2.9–11.3) |  |
 16+ (n = 27) | 22.3 (5.1–39.5) |  |
Pneumonia | Â | Â |
 Yes (n = 25) | 28.9 (9.1–48.7) | < 0.001 |
 No (n = 454) | 3.5 (1.5–5.5) |  |
Comorbidities | ||
 Hypertension |  | 0.785 |
  Yes (n = 388) | 5.3 (2.8–9.1) |  |
  No (n = 75) | 3.2 (0–7.5) |  |
 Diabetes mellitus |  | 0.523 |
  Yes (n = 128) | 4.1 (0.2–8.0) |  |
  No (n = 330) | 5.5 (2.8–8.2) |  |
 Atrial Fibrillation |  | 0.013 |
  Yes (n = 138) | 9.6 (4.1–15.1) |  |
  No (n = 319) | 4.6 (0.8–5.1) |  |
 Hypercholesterolemia |  | 0.778 |
  Yes (n = 237) | 5.7 (2.4–9.0) |  |
  No (n = 219) | 4.3 (1.4–7.2) |  |
 Previous stroke |  | 0.276 |
  Yes (n = 99) | 6.6 (0.9–12.3) |  |
  No (n = 359) | 4.6 (2.2–6.9) |  |
Biomarkers | ||
 mHLA-DR day1 |  | 0.014 |
   < =16,422 (n = 234) | 7.1 (3.6–10.6) |  |
   > 16,422 (n = 237) | 2.6 (0.2–5.0) |  |
 IL-6 day1 |  | 0.023 |
   < =4.3(n = 234) | 1.6 (0–3.4) |  |
   > 4.3 (n = 231) | 6.2 (2.9–9.5) |  |
 IL-10 day1 |  | 0.459 |
  <=5.0 (n = 387) | 3.4 (1.4–5.4) |  |
  >5.0 (n = 76) | 6.2 (0.3–12.1) |  |
 LBP day1 |  | 0.073 |
  <= 7.5 (n = 233) | 1.6 (0–3.6) |  |
  >7.5 (n = 231) | 6.3 (2.7–9.8) |  |
 TNF-α day1 |  | 0.216 |
  <=631 (n = 214) | 2.1 (0–4.3) |  |
  >631 (n = 244) | 5.8 (2.5–9.1) |  |